Posts Tagged ‘faculty’
Heart-on-a-chip may lead to new treatments for heart failure
A team led by Professors Kevin Healy and Niren Murthy have developed a microfluidic heart-on-a-chip, with which they were able to discover a lipid nanoparticle that could penetrate the dense heart muscle and efficiently deliver its cargo of therapeutic mRNA into heart muscle cells. This new drug delivery method and testing platform may pave the way to new cardiac treatments.
Read MoreTaner Sen and Colleagues Sequence Complex Oat Pangenome
Adjunct Professor Taner Sen and his colleagues at the USDA and beyond have assembled and annotated the genomes of 33 wild and domesticated oat lines, along with an atlas of gene expression across in 23 of these lines, which will enable future efforts to even more hardy and productive strains of the popular grain.
Read MoreFletcher elected to National Academy of Medicine
Professor Dan Fletcher has been elected to the National Academy of Medicine for his contributions to the mechanistic understanding of biological self-assembly and mechanotransduction, and his work developing mobile phone-based microscopy for remote diagnosis of infectious diseases. Election to the academy is considered one of the highest honors in the fields of health and medicine.
Read MoreUC Berkeley scientists uncover neural mechanisms behind long-term memory
Researchers from Professor Michael Yartsev’s lab used wireless recording devices to track neural activity in Egyptian fruit bats, revealing new clues to how our long-term memories are formed.
Read MoreKeasling Named 2025 DOE/NAI Innovator of the Year
The Department of Energy and the National Academy of Inventors have honored Professor Jay Keasling with their 2025 Innovator of the Year Award, which goes to one DOE employee who has translated research into tangible impacts that have benefited society at large. Keasling is a pioneer in synthetic biology who leads a groundbreaking research program focused on engineering microorganisms to produce advanced biofuels and chemicals.
Read MoreUC Berkeley Awards $200K Venture Grant to HypO2Regen Therapeutics
Professor Phil Messersmith and colleagues have launched HypO2Regen Therapeutics, a startup developing novel, disease-modifying therapeutics for chronic intractable inflammatory diseases, including the first cell-free stem cell treatment that induces true regeneration of damaged tissue. Their first effort takes aim at periodontitis, which affects over 300 million people worldwide.
Read MoreLareau named MTI Innovator
Professor Liana Lareau is recognized for her revolutionary approach to treat retinitis pigmentosa and other dominant genetic diseases by combining CRISPR prime editing with machine learning.
Read MoreThe not-so-secret life of gut bacteria
Computational modeling from Mofrad Lab gives us a peek inside these important microbial communities.
Read MoreMessersmith’s AsparaGlue named East Bay Innovation Awardee
Berkeley startup AsparaGlue, founded on science by Professor Phil Messersmith and postdoc Subhajit Pal, won an East Bay Innovation Award for their bioinspired surgical superglue.
Read More